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The smallest known homeodomain protein, Homeodomain only protein (Hop), was identified and described here as a temporally and
spatially restricted gene in the neurogenic regions of the developing murine CNS including the cerebral cortex. Furthermore, an
evolutionarily conserved 418 base pair upstream cis-regulatory DNA sequence was found to confine the Hop expression to the CNS of
transgenic mice, but not to the heart which is the second major Hop expressing organ (Chen, F., Kook, H., Milewski, R., Gitler, A.D., Lu,
M.M., Li, J., Nazarian, R., Schnepp, R., Jen, K., Biben, C., Runke, G., Mackay, J.P., Novotny, J., Schwartz, R.J., Harvey, R.P., Mullins, M.C.,
Epstein, J.A., 2002. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713–723; Shin, C.H., Liu, Z.P.,
Passier, R., Zhang, C.L., Wang, D.Z., Harris, T.M., Yamagishi, H., Richardson, J.A., Childs, G., Olson, E.N., 2002. Modulation of cardiac
growth and development by HOP, an unusual homeodomain protein. Cell 110, 725–735). The forebrain enhancer activity was successfully
reproduced in vitro utilizing a combination of the electroporation and the organotypic brain culture method. Using this approach, the minimal
requirement for the forebrain-specific enhancer sequence was delineated down to 200 base pairs. We further demonstrate that the Hop
enhancer activity is inducible ectopically in a transgenic tissue by wild-type roof plate transplantation in vitro. Thus Hop is regulated in the
forebrain by a so far unidentified paracrine signaling factor from the roof plate. Furthermore, the identified enhancer sequence provides an
important tool for the targeted expression of transgenes in the medial cortex and the cortical hem.
D 2005 Elsevier Inc. All rights reserved.Keywords: Homeodomain only protein; Hop; Enhancer; Cerebral cortex; Roof plate; Cortical hem; Transgene; Electroporation; Tissue transplantation; Brain
slice culture
Introduction Similar to the caudal neural tube whose patterningThe development of the mammalian cerebral cortex is
associated with an intriguing process by which certain
molecular expression boundaries are first established and
then translated into morphologically distinct domains. The
establishment of cortical area identities depends on the
concerted action of transcription factors that form expres-
sion gradients in the cortical primordium. For example, the
homeodomain transcription factors Pax6 and Emx2 show
complementary expression gradients and mice lacking either
of these genes develop displaced cortical area identities
(Bishop et al., 2000, 2002; Muzio et al., 2002b).0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.04.033
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E-mail address: kchowdh@gwdg.de (K. Chowdhury).depends on signals from the roof plate and floor plate (for
a review, see Helms and Johnson, 2003; Jessell, 2000) the
cortical patterning depends on signaling centers that are
situated at the margins of the cortical primordium and
release paracrine signaling factors (reviewed in Grove and
Fukuchi-Shimogori, 2003; O’Leary and Nakagawa, 2002).
These signaling centers are the FGF expressing anterior
neural ridge (Shimamura and Rubenstein, 1997), the WNT
and BMP expressing cortical hem (Grove et al., 1998), and
the EGF expressing anti-hem (Assimacopoulos et al., 2003).
In addition, SHH from the prechordal mesoderm and the
medial ganglionic eminence is suggested to pattern the
ventral forebrain (Kohtz et al., 1998; Shimamura and
Rubenstein, 1997). Loss of function and gain of function
studies of many of these signaling molecules demonstrate83 (2005) 522 – 534YDBIO-02001; No. of pages: 13; 4C: 5, 7, 8, 10
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Shimogori and Grove, 2001; Galceran et al., 2000; Garel et
al., 2003; Kohtz et al., 1998; Lee et al., 2000; Shimogori et
al., 2004) in part mediated by their interactions with the
Pax6 and Emx2 functions (Assimacopoulos et al., 2003;
Fukuchi-Shimogori and Grove, 2003; Muzio et al.,
2002a,b).
During the development three subdivisions become
apparent in the medial cortex, namely the cortical hem as
a transitory field adjacent to the archicortex, the choroid
plexus and most medially the telencephalic roof. The
cortical hem has been implicated in the establishment of
medial structures, such as the hippocampus. Thus, Gli3-
deficient extra toes (XTJ) mutants lack typical cortical hem
markers (Grove et al., 1998) and fail to develop a hippo-
campus (Theil et al., 1999). Similar defects are seen in mice
mutant for the cortical hem factor Wnt3a in which a
rudimentary hippocampal primordium persists and does not
develop into a mature structure (Lee et al., 2000). Finally,
the hippocampus development is altered in mice that
express a mutated form of the WNT downstream mediator
Lef1 (Lee et al., 2000).
The Emx2 gene has been established as a downstream
target of the cortical hem signaling. Thus, Emx2 expression
is absent in the cortical hem-deficient forebrain of the
Gli3XTJ/XTJ mutant (Theil et al., 1999) and the forebrain-
specific Emx2 expression is mediated by a specific enhancer
sequence which is regulated by the action of WNT and BMP
factors (Theil et al., 2002). As another signaling center in the
dorsal midline of the forebrain, the roof plate exerts a cortical
patterning function already before the cortical hem appears.
For example, the Lhx2 expression gradient in the ventricular
zone of the cerebral cortex has been shown to depend on roof
plate derived BMP signaling (Monuki et al., 2001). Both
Emx2 and Lhx2 show medial-high to lateral-low expression
gradients in the cortical ventricular zone and depend on
signaling from the medial signaling centers. It can be
assumed also that the expressions of other genes forming
similar gradients in the cerebral cortex are mediated by roof
plate or cortical hem signaling.
In spite of such detailed information about some cortical
patterning molecules (for a review, see Grove and Fukuchi-
Shimogori, 2003), our understanding of corticogenesis is far
from complete. It seems crucial to discover additional
molecules that are expressed in the developing cortex and
characterize their expression patterns. Besides the above-
mentioned medial cortex-specific Emx2 enhancer (Theil et
al., 2002), only few other cis-regulatory elements, such as
those of NF-L (Charron et al., 1995), Sox2 (Zappone et al.,
2000), Otx2 (Kurokawa et al., 2004), Ngn1 (Blader et al.,
2004), and Ngn2 (Scardigli et al., 2003), have been linked to
gene expression in the developing cerebral cortex. There-
fore, the characterization of other gene regulatory elements
underlying regionalized gene expression, such as in the
medial cerebral cortex, and linking them to the action of
cortical signaling centers will provide us a better under-standing of the gene regulation and patterning processes in
the cerebral cortex.
In order to identify such genes, which are differentially
expressed in various developing brain domains, we have
performed an Affymetrix DNA Microarray expression
analysis (manuscript in preparation). Here we describe the
spatially and temporally regulated expression of Homeo-
domain only protein (Hop) in the developing cerebral cortex
and other structures of the central nervous system. Until
now the Hop gene has been only implicated with the
development of the heart, where it is very strongly
expressed (Chen et al., 2002; Shin et al., 2002). In the
heart, Hop acts downstream of Nkx2.5 inhibiting gene
transcription by either direct interactions with the tran-
scription factor SRF (serum response factor; Chen et al.,
2002; Shin et al., 2002) or recruitment of histone
deacetylase activity (Hamamori and Schneider, 2003).
Neither the function of Hop nor its regulation in the
cerebral cortex had been studied so far.
As described here, the Hop gene is expressed in the
developing medial cortex and cortical hem as well as other
structures of the central nervous system, such as the neural
tube and cerebellum. Subsequently, we have identified a
418-bp Hop enhancer element that confined lacZ reporter
expression specifically to all Hop-positive sites within the
central nervous system of transgenic mice. Applying a novel
method that involves electroporation and organotypic brain
culture, we then established the minimal sequence require-
ments of the forebrain activity of the Hop enhancer being
represented in a 200-bp sequence. The 200-bp forebrain
enhancer of Hop does not contain functional transcription
factor binding sites that have been shown to be involved in
cortical gene regulation thus far. However, our trans-
plantation experiments in vitro demonstrate a dependence
of the activity of the Hop forebrain enhancer on roof plate
signaling. The Hop forebrain enhancer can therefore be
regarded as a novel sequence element activating tran-
scription in the medial cerebral cortex downstream of roof
plate signaling.Materials and methods
Mouse strains
The outbred mouse strain NMRI is maintained in our
laboratory. Inbred FVB female mice were obtained from
Harlan Winkelmann. Lef1-deficient mice were obtained
from the laboratory of Dr. R. Grosschedl (University of
Munich) and genotyped as previously described in Galceran
et al., 2000.
Sequence alignment and analysis
Murine and human genomic sequences were obtained
from the CELERA database (Kerlavage et al., 2002) and
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1994). Potential transcription factor binding sites were
searched in the TRANSFAC database (Wingender et al.,
2000) utilizing the MatInspector program (Quandt et al.,
1995).
Microarray hybridization
E16.5 NMRI brains were dissected in ice-cold PBS.
Small portions from the rostral and caudal thirds of the
medial cortex as well as the frontal, parietal, and occipital
lateral cortex were dissected out and collected in RNA later
(Ambion). Tissue from several embryos was pooled and
total RNA was extracted utilizing the QIAGEN RNeasy
system (Qiagen). RNA labeling, hybridization, and analysis
of the MGU74v2 series of microarrays (Affymetrix) were
performed as described in the manufacturers guidelines. A
manuscript concerning our microarray expression analysis is
in preparation.
In situ hybridization
NMRI whole embryos or isolated brains were fixed in
ice-cold 4% PFA and processed for paraffin or cryosection-
ing following standard histology protocols. The 255-bp
DraIII fragment of RIKEN clone AK009007 was cloned
blunt ended into the SmaI site of pBluescript II KS+
(Stratagene) and used to generate the Hop-specific RNA
probes. DIG or radioactively labeled probes were transcribed
with T3 RNA polymerase (for antisense) or T7 (for sense).
In situ hybridization was performed as previously described
(Moorman et al., 2001; Stoykova and Gruss, 1994).
Plasmid construction and mutagenesis
For transgenic analysis, several genomic DNA fragments
were PCR amplified using PCR primers with introduced SalI
restriction sites and subsequently cloned into the SalI site
(pD1, pD3–pD9) or XhoI site (pD2) of the pTrap vector
(Pfeffer et al., 2000). After subcloning into pTrap, all PCR
produced fragments were sequenced using a beta-globin reverse
primer (5VAGCAATAGATGGCTCTGCCCTGAC). The primer
pairs used for amplification were as follows (SalI sites underQ
lined, mutated bases in bold): pD1, pD2, forward 5VAAAQ
GTCGACCAACTTTCAAAGGCTTTACGTTTC, reverse
5VAAAGTCGACGAAGAGTGGCTTAAGGGCTCTGC; pD3,
forward 5VAAAGTCGACTAGATCTCTTTGACACACTC,
reverse 5VAAAGTCGACAACAGCTGCCTGCTAGCAG;
pD4, forward 5VAAAGTCGACTCCCTGGCTGCCTGCGGC,
reverse 5VAAAGTCGACTAATAGCCTCCTGTTCTAAAAG;
pD5, forward 5VAAAGTCGACTCCCTGGCTGCCTGCGGC,
reverse 5VTTTGTCGACAAGGCAGTCAGCACAA-
GTCGACAAGGCAGTCAGCACAAGGGTGGATTTC;
pD6, forward 5VAAAGTCGACTCCCTGGCTGCCTGCGGC,
reverse 5VAAAGTCGACAGGCATCTTAATTCCTGGCTG;
pD7, forward 5VAAAGTCGACTGGTCTCCAAGACAGCTCC,reverse 5VAAAGTCGACTAATAGCCTCCTGTTCTAAAAG;
pD8, forward 5VAAAGTCGACAGCCGCTAAGCGG-
GTCGACAGCCGCTAAGCGGTAGTCAC, reverse 5VAAAQ
GTCGACTGCCTGCTAGCAGAAGTCAC; pD9, forward
5VAAAGTCGACTCCGCTTTTGTTGACAGAG, reverse
5VTTTGTCGACAAGGCAGTCAGCACAAGGGTGGATTTC;
pD5DOct6, forward 5VAAAGTCGACTCCCTGGCTGCCQ
TGCGGC, reverse 5VTTTGTCGAC AAGGCAGTCAGCAQ
CAAGGGTGGATTTCACAGGCATCTTGGATCCTG.
For the mutation of both putative TCF/Lef1 binding
motifs in pD3DTCF two PCR reactions with the primer
pairs 5VAAAGTCGACTCCCTGGCTGCCTGCGGC/
5VCTTTCTTTTCGGCTTGATAGTTGGCCCTTGGC and
5VGCCAAGGGCCAACTATCAAGCCGAAAAGAAAG/
5VAAAGTCGACTGCCTGCTAGCAGAAGTCAC were
performed. The PCR products were cleaned up, annealed,
and further used as templates for a subsequent PCR reaction
with the forward mutated primer 5VAAAGTCGAC
TCCCTGGCTGCCTGCGGCTTGCTTTCTATGGCATG
TTACTTTAGAC and the reverse primer 5VAAAGTCGAC
TGCCTGCTAGCAGAAGTCAC. The final product was
cloned and sequence verified.
Generation and analysis of transgenic mice
Transgenic mice were generated by microinjection of
fertilized eggs from FVB mice as described previously
(Brink et al., 2001) and were identified by polymerase chain
reaction using tail DNA. Expression of the transgene was
analyzed by staining whole mouse embryos or sectioned
brains for h-galactosidase activity following standard
protocols (Gossler and Zachgo, 1993). Sections were
counterstained using 0.1% neutral red.
Electroporation
Plasmid DNA for electroporation was prepared with the
QIAGEN Plasmid Maxi Kit (Qiagen), 1 phenol-chloro-
form, and 1 chloroform extracted, precipitated, and
dissolved in sterile PBS. 2–3 Al of a plasmid solution
containing 700 ng/Al of a construct driving an EGFP
sequence from a CMV promoter (CMV-EGFP; Spieler et
al., 2004) and 400 ng/Al of a deletion construct of interest
(pD) were microinjected into the lateral ventricle of isolated
E14.5 brains (NMRI) using microcapillaries from Clark
Electromedical Instruments. Injected brains were placed
between 8 mm distant platinum electrodes and five
rectangular 70-V pulses with 50 ms duration and 1 s
intermission were applied using an Electro Square Porator
ECM 830 (Btx Inc.).
Organotypic slice culture and roof plate transplantation
For brain slice culture, electroporated or transgenic
brains were embedded in 2% low melting point agarose
(Invitrogen) in EBSS (Gibco BRL) and vibratome sectioned
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Systems). Protocols for organotypic slice culture were
modified from previous publications (Anderson et al.,
1997) using 0.3 Am polycarbonate tissue culture inserts
(Nunc) and Neurobasal A medium (Gibco BRL), supple-
mented with 1 B27 (Gibco BRL), 10% fetal calf serum
(Pan Biotech GmbH), 50 Ag/ml streptomycin (Gibco BRL),
50 U/ml penicillin (Gibco BRL), and 2 mM glutamine
(Gibco BRL). Tissue culture was performed at standard
conditions (5% [CO2], 95% humidity, 37-C).
For transplantation experiments, E10.5 wild-type fore-
brains were dissected as illustrated in Fig. 4A. Dorsal
midline tissue corresponding to the roof plate, or ventral
forebrain tissue corresponding to the ganglionic eminence,
were removed and placed in direct contact to the ventral
and lateral pallial regions of organotypically cultured
transgenic brain slices. Transplanted tissue was in part
visualized by briefly dipping it in inert dyes, such as DiI
or carmine red (Sigma). After 48 h, brain cultures were
fixed for 30 min with 1% formaldehyde/0.2% glutaralde-
hyde/0.02% NP-40 in PBS and further processed for lacZ
staining.
Image recording and processing
Images were recorded with a digital camera (Colerview
12) on a microscope (BX60, Olympus) or binocular
(SZX12, Olympus). EGFP signals were visualized using
an MGFP filter from Olympus. Images were processed and
mounted using Photoshop 6.0 (Adobe).Results
The Hop gene is expressed in the developing nervous system
in a temporally and spatially restricted fashion
Using Affymetrix DNA microarrays for expression
analysis we identified Homeodomain only protein (Hop)
as a highly regionalized gene in the E16.5 cerebral cortex
(manuscript for the microarray expression screen in prep-
aration). Hop, whose cortical expression was briefly
reported elsewhere (Funatsu et al., 2004), showed the
highest hybridization signal in samples of the rostro-medial
cortex, whereas the hybridization signals in samples of the
frontal, parietal, occipital, and caudo-medial cortices were
reduced by the fold changes of 2.6, 3.0, 3.7, and 1.9,
respectively.
In situ hybridization experiments revealed that at E11.5
(embryonic day 11.5) Hop transcripts are present in the
heart, in the ventricular zone (vz) of the spinal cord, and in
a specific hindbrain region that corresponds to the
prospective cochleo-vestibular nucleus. No expression
was detectable in the developing forebrain at this stage
(Figs. 1A and B). First forebrain expression was detectable
at E12.5 in the most medial aspect of the cortex, the anlageof the archipallium. At E12.5 Hop expression persisted in
the ventricular zone of the spinal cord, in the anlage of the
cochleo-vestibular hindbrain nucleus, and in the heart (Figs.
1C and D). At E11.5 as well as at E12.5 the expression of
Hop in the ventricular zone of the spinal cord was higher in
the basal plate than in the alar plate and absent from the
floor plate and roof plate (Figs. 1B and D). The forebrain
expression level continued to remain low at E14.5 (Figs.
1E–G) but became higher and reached its peak at E16.5.
At this stage the Hop expression formed an expression
gradient in the cortical ventricular zone with high expres-
sion rostro-medially and low expression caudo-laterally
(Figs. 1H–J). In addition, the cortical hem and a stream of
cells leaving the dentate notch towards the developing
dentate gyrus became Hop positive (Fig. 1I). Expression at
E18.5 resembled that of E16.5 with more Hop-positive
cells having reached the dentate gyrus (Figs. 1K–M). We
further examined the postnatal expression at P6 and found
that cells in the ependymal layer, the CA3 field of the
hippocampus, and the entire dentate gyrus express Hop
(Figs. 1N–P). Eventually little Hop message was detect-
able in the adult cerebral cortex (P21) where positive cells
were solely found in the subgranular layer of the dentate
gyrus. Due to their distribution pattern and sparseness,
these cells resemble much the dentate gyrus stem cell
population (Fig. 1Q). However, their identity remains at
this time elusive. At P6 and P21 strong Hop expression
was seen in the cerebellum in cells surrounding the
Purkinje cells, thus most likely representing a subpopula-
tion of the Bergmann glia cells (arrowheads Figs. 1P and
R). An in situ hybridization using sense RNA probes on
E16.5 cortex yielded no signal and served as a control (data
not shown). Taken together, Hop expression is subject to a
temporal and spatial regulation during vertebrate nervous
system development.
We then focused primarily on the identification and
characterization of the regulatory sequence elements under-
lying the highly regionalized expression of Hop in the
nervous system, in particular the cerebral cortex.
The Hop gene expression in the nervous system is regulated
by a specific enhancer sequence
Indispensable genes and gene regulatory sequences are
highly conserved during evolution. A DNA sequence
comparison between the mouse and the human Hop loci
revealed the existence of a 418-base pairs (bp) element (Hop
E1) located about 7 kb upstream of the first exon and
containing 340 nucleotide identities between the two
genomes (Figs. 2A and B). Within the examined sequences
no other conserved element of similar quality was found.
Database search revealed no transcripts containing the E1
sequence, thus indicating that E1 is likely to be a conserved
regulatory element.
To test this idea, we generated transgenic mice with a
706-bp genomic fragment encompassing the 418-bp Hop
Fig. 1. Hop gene expression in the developing mouse embryo as detected by in situ hybridization. At E11.5 (A, B) and E12.5 (C, D) Hop expression was
detected in the heart (ht) and neural tube (nt) as well as in the anlage of the nucleus cochleo-vestibularis of the hindbrain (nc). From E12.5 onwards Hop
transcripts became apparent in the medial cortex (mc, C) where they persisted at E14.5 (mc, E–G). Later on, at E16.5 (H–J) and E18.5 (K–M), strong Hop
expression was seen in the cortical ventricular zone (vz) forming a medial-high to lateral-low gradient. At these stages Hop transcripts were further seen in the
cortical hem (he) and developing dentate gyrus (dg). At P6 Hop expression was detected in the entire dentate gyrus (dg, N), the CA3 field of the hippocampus
(CA3, N), the ependymal cell layer (ec, O), and in the cerebellum in cells that most likely represent a subpopulation of the Bergmann glia cells (arrowhead in
P). In the adult brain Hop expression persisted in these cells (arrowhead in R) and in the subgranular layer of the dentate gyrus (dg, Q). Gl, granular layer; ml,
molecular layer. Scale bars are equal to 500 Am (A, B; C, D; H–J; K–M), 400 Am (E–G), and 250 Am (N–P; Q, R).
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reporter gene cassette (construct pD1; Fig. 6A). Analyses of
these mice showed that indeed the 706-bp fragment was
able to mimic the lacZ reporter activity in the Hop
expressing regions of the embryonic brain and the spinal
cord (compare Figs. 1 and 3). Such lacZ activity patterns
were reproduced in three out of five independent transgenic
mouse lines. When we compared the lacZ patterns among
these positive mouse lines some variable ectopic reporter
activity was observed, most likely due to different integra-
tion sites among the independent transgenic lines. No
reproducibly specific reporter activity was detected outside
the nervous system. Especially the heart, the major Hop
expressing organ, was devoid of reporter activity. We
concluded that the E1 element (plus the flanking sequences
present in the construct) serves as a nervous-system-specific
enhancer for the Hop expression. The kinetics and
expression of the lacZ reporter activity in one founder line
are shown in Fig. 3.At E12.5 the specific beta galactosidase reporter activity
was detected in the medial cerebral cortex, the anlage of the
cochleo-vestibular nucleus of the hindbrain, and the
ventricular zone of the spinal cord (Figs. 3I–K). The lacZ
staining in the ventricular zone of the spinal cord was strong
in the most dorsal part of the alar plate and reduced in the
entire basal plate, the floor plate and the roof plate were
devoid of reporter activity (Fig. 3K). In the E16.5 cortex,
lacZ was detectable in the ventricular zone of the rostro-
medial cortex (Fig. 3L), the cortical hem, and cells
migrating from the dentate notch towards the developing
dentate gyrus (Fig. 3M). Thus, the E1 enhancer-driven
reporter activity strongly correlated with the Hop expression
in the developing nervous system. Merely some divergence
was noticed in the most lateral ventricular zone of the E16.5
cortex where no lacZ activity (Fig. 3L), but slight Hop
expression was seen by in situ hybridization (Fig. 1H). The
presence of other Hop enhancer sequences, which might
exist and extend the expression further laterally, cannot be
Fig. 2. Location and sequence of the evolutionarily conserved Hop E1 upstream regulatory element. A conserved 418-bp sequence element is situated
approximately 7 kb upstream of the first exon (A) and reveals a high degree of sequence conservation between the murine and human genomes (B). The Hop
E1 element contains putative transcription factor binding sites (core bases capitalized), amongst them two TCF/Lef1 binding motifs and one Oct6 binding
motif. Restriction enzyme sites shown in panel A are as follows: D, DraII; H, HincII; M, MboI; P, PstI.
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element seems to account for most of the Hop-specific
expression in the cortex, hindbrain, and spinal cord; but not
other organs, such as heart.
We further examined the temporal expression pattern of the
Hop E1 transgene in three transgenic mouse lines. The
endogenous Hop gene expression and the transgene expression
correlated well in the neural tube, where they first appeared at
E11.5 (Chen et al., 2002; Shin et al., 2002; this publication). In
the dorsal forebrain, the Hop expression started at E12.5 (Fig.
1C), while enhancer-driven lacZ was detectable already as early
as E10.5 (Fig. 3D). One reasonmight be that the low expression
level at earlier stages could not be detected due to the lower
sensitivity of the in situ hybridization as compared to the
transgenic lacZ activity. Alternatively, additional negative
regulatory sequences might be responsible for an early
repression of the Hop transcription.
Ectopic roof plate transplants are able to induce Hop
enhancer activity
In the medial forebrain the roof plate and the cortical hem
are strong sources of paracrine signaling molecules, such as
members of the BMP and WNT families (Furuta et al., 1997;Grove et al., 1998). As mentioned above, the medial-high to
lateral-low expression gradients of Emx2 and Lhx2 in the
cerebral cortex have been suggested to depend on the
signaling from these medial signaling centers (Bulchand et
al., 2001; Theil et al., 2002). To assess whether also the
medial-high to lateral-low gradient of Hop expression and
enhancer activity depends on paracrine signaling from the
medial signaling centers, we performed a series of trans-
plantation experiments in vitro. In these experiments fore-
brains from E11.5 to E14.5 pD1-transgenic embryos were put
in organotypic slice culture (acceptor). Transplants were
isolated from the dorsal midline of E10.5 wild-type fore-
brains (donor), thus representing the roof plate, and trans-
planted into the lateral forebrain regions of acceptor tissue
that are normally devoid of Hop expression and enhancer
activity (Fig. 4A). Whereas endogenous enhancer activity
was always present in the medial cortex of the acceptor tissue,
successful transplants yielded additional ectopic enhancer
activity in the lateral forebrain (arrowheads in Fig. 4B).
However,Hop enhancer activity could be induced only when
the recipient brains were taken from stages E11.5 (Fig. 4B) or
E12.5, but not older (data not shown). From this observation
we concluded that roof plate signals are sufficient to induce
Hop enhancer activity in the forebrain and that the
Fig. 4. Strategy and results of the in vitro roof plate transplantation
experiments. Either roof plate (rp) or ganglionic eminence (ge) tissues were
taken from wild-type E10.5 embryonic brains and transplanted into the
ventral pallium of E11.5 pD1-transgenic brains (A). After 2 days in slice
culture the recipient forebrains developed ectopic enhancer activity in the
lateral and ventral pallial regions overlaying the roof plate transplants
(arrowheads, B). No enhancer induction was seen after transplantation of
E10.5 ganglionic eminences (asterisk, C) into the lateral E11.5 forebrain. The
transplanted tissues were visualized with karmin red (B, C). In all transgenic
brains the endogenous enhancer activity was present in the medial cortex and
cortical hem (B, C). Scale bars are equal to 500 Am (B–C).
Fig. 3. The Hop E1 element is capable of driving the lacZ expression from a minimal beta globin promoter in vivo. At E11.5 (E–H), E12.5 (I–K), and E16.5 (L,
M) lacZ activity was detected in regions that showed strongHop expression (also compare to Figs. 1E–M), such as the ventricular zone of the neural tube (nt; E,
G, K), the medial cerebral cortex (mc; D, F, I), and the cortical hem (he; G, M), the anlage of the nucleus cochleo-vestibularis of the hindbrain (nc; E, H, J), the
ventricular zone of the rostro-medial cortex (vz; L), and the developing dentate gyrus (dg; M). Ectopic lacZ was present in the mesencephalic tegmentum
through several stages (tg; B, C, E), in the pretectum (pt; D, E), the anlage of the mammillary bodies (mb; C, E), as well as in the ribs (E). At E8.5 no lacZ
activity was present in the developing central nervous system including the forebrain (fb; A). The heart (ht; B, C, E) was devoid of lacZ activity at all stages.
Scale bars are equal to 500 Am (A, B; C, D; E, F; G, H) and 250 Am (I–M).
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older than E12.5. Control transplants taken from wild-type
E10.5 ganglionic eminences were incapable of inducing
enhancer activity (asterisk in Fig. 4C).
An electroporation-based system for the delineation of the
Hop-specific enhancer sequence in brain slice cultures
To further delineate the sequence requirements of E1 to
act as an enhancer we adapted an in vitro system
combining electroporation-mediated plasmid transfer and
organotypic brain culture. Utilizing this approach we aimed
at a high throughput screening of deletion constructs to
identify the minimal sequence requirement for the Hop E1
activity.
For electroporation, a plasmid containing solution was
injected into the lateral ventricle of E14.5 wild-type brains.
Thereafter the brains were placed in drops of PBS centered
between electrodes (Fig. 5A). Five 70-V pulses were
applied. The electroporated brains were vibratome sec-
tioned and put in culture. After 24 h the slice cultures were
fixed and stained for lacZ activity. To monitor the exact
sites of electroporation a CMV-EGFP (CMV promoter
driven enhanced green fluorescent protein sequence)
plasmid was coelectroporated with the deletion construct
of interest.
We first determined whether the enhancer activity pattern
seen in vivo (in transgenic mice) is reproducible through
Fig. 5. Electroporation and organotypic slice culture strategy. The pro-
cedure of electroporation-mediated gene transfer involves the injection of a
DNA solution into the lateral ventricle of E14.5 brains (A, 1), followed by
vibratome sectioning (A, 2) and 24 h of organotypic slice culture (A, 3).
CMV-EGFP, a plasmid expressing the EGFP cDNA from the CMV
promoter, and pD1, a plasmid containing the Hop E1 element and a beta
globin minimal promoter-lacZ cassette, were coelectroporated. EGFP-
positive cells were typically seen in the rostro-medial (rm, C) and caudo-
medial (cm, E) as well as in the diencephalic (di, E) ventricular zone.
Among the targeted regions only the rostro-medial cortex (B), but not the
caudo-medial cortex or the diencephalic region (D) developed E1-driven
lacZ activity, thus reflecting the regional specificity of the enhancer activity.
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plasmid mixture of CMV-EGFP and pD1 was electro-
porated. When the anode was placed towards the uninjected
hemisphere (Fig. 5A), a typical pattern of EGFP-positive
cells was seen in the medial ventricular zone (Fig. 5C). Due
to some leakage of plasmid solution through the interven-
tricular foramen, EGFP-positive cells were also present in
the diencephalic ventricular zone (Fig. 5E). Among the
EGFP-positive electroporated brain regions, only the rostro-
medial cortex, but not the caudo-medial cortex or the
diencephalic ventricular zone developed lacZ activity (Figs.
5B and D). The in vivo regional specificity of E1 activity
along the rostro-caudal axis and the telencephalic–dience-
phalic subdivision was therefore well preserved and
reproducible in vitro.
We then proceeded to perform further deletion analyses
of the Hop E1 enhancer fragment by the electroporation
and organotypic culture method. To begin with, we
electroporated two pD1 plasmid versions containing the
enhancer in sense and antisense orientation as well as pD2
containing the 706-bp enhancer fragment located at the 3V-
end of the LacZ cassette (Fig. 6A). In all these experi-
ments full reporter activity was observed (Figs. 7A–C,
AV–CV). Hop E1 therefore fulfils all criteria of a classical
enhancer, namely independence of position and orientation
from the promoter (Banerji et al., 1981; Fromm and Berg,
1983).We attempted next to delineate the minimal sequence
requirements of the Hop enhancer activity in the medial
pallium. pD3, another deletion construct, contained only
the 418-bp element conserved between the human and
the mouse genome (Fig. 6A). With pD3 full reporter
activity was observed (Figs. 7D and DV). Of the several
putative transcription factor binding sites predicted by
MatInspector (Quandt et al., 1995), two TCF/Lef motifs
in pD3 attracted our attention. The Lef1 transcription
factor is strongly expressed in the ventricular zone of the
medial cortex (Galceran et al., 2000) and might therefore
account for the Hop enhancer activity. However, a
deletion construct containing the 418 bp conserved E1
element with point mutations in both TCF/Lef motifs
(pD3DTCF; Figs. 6A and B) showed reporter activity
that was identical to that of the non-mutated plasmid
(compare Figs. 7D, DV, E, and EV).
Further deletion analyses allowed us to establish a 200-
bp minimal enhancer sequence (pD5; Fig. 6A) yielding
strong reporter activity (Figs. 7G and GV). The 200-bp
minimal enhancer could not be further deleted at its 5V- or
3V-ends without severely reducing or abolishing its activity
(pD6 and pD9; Figs. 6 and 7I, IV, L, LV). A putative Oct6
binding motif was also detected in the 200-bp fragment,
which might be essential for its enhancer activity. Mutating
this binding motif (pD5DOct6; Figs. 6A and B) however
did not abolish reporter activity (Figs. 7H and HV), thus
indicating its dispensability. Moreover two 180-bp sub-
fragments from the center or the 3V regions of E1 (pD7 and
pD8; Fig. 6A) did not result in any enhancer activity (Figs.
7J, JV, K, and KV), thus corroborating the fact that the
construct pD5 harbors the minimal enhancer element. For
the sake of reproducibility and comparability among all
experiments, the electroporation, culture, and staining
conditions were kept constant and the CMV-EGFP plasmid
was included as an internal control.
Among the TCF/Lef transcription factors, Lef1 shows the
strongest expression in the medial cortex (Galceran et al.,
2000). However, as mentioned above, our deletion analysis
suggested that the putative TCF/Lef binding sites in the Hop
enhancer are dispensable and that the corticalHop expression
might therefore not depend on the Lef1 transcription factor.
Further support for this assumption was gained from the
analysis of the Hop expression in the cerebral cortex of Lef1-
deficient brains. As expected, the expression of Hop was
neither absent nor reduced in the Lef1-deficient cortex when
compared to wild type (data not shown).Discussion
Hop is expressed in the neurogenic regions of the embryonic
CNS
Here we identified the Homeodomain only protein (Hop)
as a gene with spatially and temporally regulated expression
Fig. 6. Deletion mapping of theHop E1 enhancer element. For deletion analysis several sub-fragments of E1 were linked to a beta globin minimal promoter-lacZ
reporter cassette and tested for their enhancer activity in the medial cortex utilizing electroporation in organotypic slice culture (A). Full enhancer activity was
thereby detected with constructs containing the E1 sequence independent of its position and orientation (A: pD1, pD2, 706 bp; pD3, 418 bp). pD4 (295 bp) or pD5
(200 bp) also yielded comparable enhancer activity (A). Further deletions (A: pD6, pD9) almost completely abolished the enhancer activity. Other sub-fragments
of the PD3 construct were without enhancer activity (A: pD7, pD8). The mutation of putative TCF/Lef1 and Oct6 binding sites within the E1 sequence had no
effect on its enhancer activity (A: pD3DTCF, pD5DOct6). The introduced point mutations are shown in panel B. For comparison see also Fig. 7.
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expression at sites of neurogenesis, such as the ventricular
zone of the spinal cord and the cortex, the subgranular layer
of the dentate gyrus, and the ependymal cell layer, suggests
Hop as a putative regulator of proliferation and/or differ-
entiation. Interestingly a similar function has been shown for
Hop in cardiac development (Chen et al., 2002; Shin et al.,
2002).
Hop lacks DNA binding activity and therefore does not
directly regulate transcription. During cardiogenesis it acts
as an antagonist of the transcription factor SRF (Chen et
al., 2002; Shin et al., 2002). A similar mechanism of Hop
activity in neurogenesis seems to be unlikely because we
failed to detect any SRF protein in the ventricular zone of
the E13.5 and E16.5 medial cortex using immunohisto-
chemistry (data not shown). The applied rabbit anti-SRF
polyclonal antibody (Santa Cruz) was capable to detect
SRF protein in the heart, which thereby served as a
control.
In addition to a putative function in neurogenesis, Hop
might be associated with the establishment and/or main-
tenance of the dentate gyrus cells as they are Hop-positive
during all phases of their development such as birth at thedentate notch, migration towards the dentate gyrus, and its
colonization.
The spatially and temporally restricted expression of
Hop in diverse tissues like brain and heart suggested that
separate cis-regulatory elements control the activation and
subsequent maintenance of Hop expression in different
organs.
A novel enhancer confines expression to Hop-positive
structures of the CNS
A regulatory sequence element located in the first
intron of the Hop gene locus and capable of driving Hop
expression solely and specifically in the heart has been
described (Chen et al., 2002). Transcriptional activation
from this cardiac Hop enhancer was mediated through the
action of the Nkx2.5 transcription factor. However, this
cardiac sequence element does not account for the strong
Hop expression in the nervous system. By genomic DNA
sequence comparison of the Hop locus we first identified
a sequence element (Hop E1 element) with high
conservation between the murine and the human
genomes. Transgenic mouse lines were established with
Fig. 7. Mapping of the Hop E1 enhancer activity. lacZ staining indicates enhancer activity detected after electroporation of various E1 deletion constructs (see
Fig. 6A) into E14.5 brains and 24 h organotypic slice culture (A–L). The corresponding targeted regions are marked through the fluorescence of the
coelectroporated CMV-EGFP plasmid (AV–LV). Strongly reduced or completely absent enhancer activity was detected with deletion constructs lacking the 200-
bp E1 minimal enhancer region (pD6–pD9; I–L, IV–LV).
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driving a minimal promoter-LacZ cassette. This novel
DNA element was able to act as an enhancer and direct
the lacZ reporter activity specifically to sites of the
embryonic CNS that strongly correlate with sites of Hop
expression, namely the ventricular zone of the neural
tube, the anlage of the nucleus cochleo-vestibularis of the
hindbrain, the forebrain roof plate and cortical hem, the
rostro-medial cortical ventricular zone, and cells migrat-
ing from the dentate notch towards the dentate gyrus. E1-
mediated transcription was completely absent from the
developing heart at all investigated stages. Taken
together, Hop expression in the developing heart and
CNS is regulated through mutually exclusive cis-regu-
latory elements.Hop E1 enhancer activity can be reproduced in vitro by a
novel approach involving electroporation and organotypic
slice culture
In the past electroporation-mediated gene transfer has
been proven to be a versatile tool to study aspects of
embryonic development (for a review, see Blader et al.,
2004). Thereby electroporation was either performed in
utero (Bai et al., 2003; Fukuchi-Shimogori and Grove,
2001; Tabata and Nakajima, 2001) or in vitro followed by
whole embryo culture (Osumi and Inoue, 2001) or organo-
typic culture (Alifragis et al., 2004; Stu¨hmer et al., 2002).
Here we developed a modified variant of the electroporation
and organotypic culture approach. Utilizing this technique
we were able to reproduce the forebrain activity of the Hop
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manner. Whereas the rostro-medial ventricular zone showed
strong enhancer activity in vivo (Fig. 3L) and after
electroporation in vitro (Fig. 5B), the caudo-medial ven-
tricular zone of the cortex (Fig. 3M) and the diencephalic
ventricular zone lacked enhancer activity in vivo as well as
after electroporation in vitro (Fig. 5D). The all over good
preservation of region specificity allowed us to perform the
further deletion analyses of the forebrain E1 activity in vitro.
The electroporation and organotypic culture-based
method presented here has the potential to complement
the transgenic-based models of enhancer study. Salient
features of this approach are its complete independence
from genome integration site effects as they are seen in
transgenic models and its high throughput capacity.
Hop expression in the forebrain requires a 200-bp minimal
enhancer sequence
Applying the electroporation and organotypic culture
method we could demonstrate that the Hop E1 element
fulfils all criteria of being a classical enhancer element, such
as independence of orientation and location from the
promoter (Banerji et al., 1981; Fromm and Berg, 1983).
Moreover, we could define the minimal requirements of
Hop E1 enhancer activity in the forebrain being represented
in a 200-bp sequence at the 5V-end of the conserved region.
Interestingly, the 3V half of the conserved region was
dispensable for the forebrain-specific enhancer activity.
Due to its strong activity the 200-bp Hop enhancer seems
to carry all sequence motifs necessary for transcription
activation in the medial forebrain. Although Lef1 is strongly
expressed in the Hop-positive rostro-medial cortex, muta-
tions in two putative TCF/Lef binding sites did not prove
these motifs to be functional for Hop expression. A normal
expression of Hop in the Lef1-deficient cerebral cortex (data
not shown) additionally emphasizes that the cortical Hop
expression is independent of this transcription factor. The
lack of effect after deletion of the corresponding putative
binding sites can be explained as follows. These 4-base pair
‘‘sites’’ are not in any case optimal canonical sites for those
factors though they are indeed the cores thereof. But these
sites are so short that in a sequence of the total length shown
here, their occurrence on a random basis is statistically not
unlikely. Due to the lack of other known and functional
transcription factor binding sites in the 200-bp minimal
enhancer, it represents a novel element conferring gene
expression to the medial cortical ventricular zone with yet
unknown transcription factors binding to it.
Forebrain activity of the Hop E1 enhancer is inducible
ectopically through roof plate transplants in vitro
The cortical medial-high to lateral-low expression gra-
dients of Emx2 and Lhx2 are assumed to depend on
diffusible signals from the medial signaling centers, theroof plate, and cortical hem (Bulchand et al., 2001; Monuki
et al., 2001; Simeone et al., 1992). Here we provide
experimental data suggesting that also the cortical expres-
sion of Hop depends on a medial signaling center, namely
the roof plate. E10.5 wild-type roof plates that were brought
into direct contact with transgenic brain in vitro, induced
Hop E1 activity at sites usually devoid of enhancer activity,
namely the lateral and ventral pallium (Fig. 4). We found
that this inductive capacity is specific for roof plate tissue
since transplantation experiments with tissue from the
ganglionic eminences did not yield ectopic enhancer
activity.
Although the transplanted roof plate tissues were always
placed underneath the transgenic brain sections, the induced
enhancer activity developed throughout its entire thickness
of 350 Am. We suggest that this action at a distance is due to
paracrine factors secreted by the transplanted roof plate
tissue. Indeed, it is an accepted model that the forebrain roof
plate acts as a source of diffusible activity, including BMP
factors (Furuta et al., 1997). However, a direct dependence
of the Hop enhancer activity on the BMP-mediated pathway
cannot be suggested, since functional binding sites for its
downstream mediators of the SMAD family were absent.
The competence of transgenic forebrain tissue, to res-
pond to roof plate signals by up regulating the Hop
enhancer activity, changed over time. The induction was
high in E11.5 brains but strongly reduced or absent in older
brains (data not shown). This disappearance of competence
correlated chronologically with the onset of Hop expression
in the medial cortex at E12.5. The induction of Hop E1
activity in the forebrain therefore seems to depend on roof
plate signals, while its maintenance becomes roof plate
independent from E12.5 onwards. However, both aspects,
induction and maintenance of Hop expression, are appa-
rently mediated by the same enhancer sequence.
In general, cortical gene expression is assumed to
become an intrinsic feature of certain regions of the cerebral
cortex at early stages of development. For instance, the
expression of marker genes, such as SCIP, KA1, and Steel,
has been shown to become intrinsic to the hippocampal
anlage and independent from roof plate/cortical hem signal-
ing at stages earlier than E12.5 (Tole and Grove, 2001).
Similar findings apply to the marker transgene H-2Z1
becoming an intrinsic feature of the prospective somato-
sensory area as early as E11.5 (Gitton et al., 1999).
Furthermore, the commitment of regional identity in the
cerebral cortex around the time of first neuronal production
is consistent with results from transplantation experiments
in the rat cerebral cortex (Barbe and Levitt, 1991) and chick
optic tectum (Itasaki et al., 1991).
In conclusion, the Homeodomain only protein, Hop, is
expressed and regulated in the developing murine forebrain
by a 200-bp-specific cis-regulatory sequence. One or more
so far unidentified paracrine signaling factor(s) from the
roof plate can turn on the Hop enhancer-mediated tran-
scriptional activity. The identified enhancer sequence
S. Mu¨hlfriedel et al. / Developmental Biology 283 (2005) 522–534 533provides an important tool for the targeted expression of
transgenes in the medial cortex and the cortical hem.Acknowledgments
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